• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压患者血浆 D-二聚体水平与疾病严重程度相关:一项比较性横断面研究。

Plasma D-dimer levels are correlated with disease severity among hypertensive patients: A comparative cross-sectional study.

机构信息

Heart Center, Wuhan Asia Heart Hospital Affiliated Wuhan University of Science and Technology, Wuhan, China.

Department of Pathology and Clinical Laboratory (DPCL), Wuhan Asia Heart Hospital (WAHH), Wuhan University of Science and Technology, Wuhan, China.

出版信息

Medicine (Baltimore). 2022 Sep 9;101(36):e30281. doi: 10.1097/MD.0000000000030281.

DOI:10.1097/MD.0000000000030281
PMID:36086694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9646652/
Abstract

It has been reported that inappropriate acute thrombus formation is the pathophysiological substrate underlying increased risk and severity of target organ damage in hypertension (HTN). However, the relationship between severity of HTN and D-dimer has not been well characterized. The study was aimed to assess plasma D-dimer level and its correlation with disease severity among hypertensives. A comparative cross-sectional study was conducted at Wuhan Asia Heart Hospital among 100 participants (60 hypertensives and 40 controls). The correlation between variables were determined using correlation coefficients, regression analysis, and also using different parametric and nonparametric tests. We observed higher D-dimer levels among hypertensives compared to the healthy controls (P < .001). The D-dimer levels were found to be increased significantly with the severity of HTN (P < .001). D-dimer was found to have a diagnostic power of 86.9% in differentiating complicated from uncomplicated HTN at 0.83 mg/L cutoff value. This study suggests that D-dimer level was higher among hypertensives than control groups and it was also increasing significantly with the severity of HTN. This suggests that hypercoagulability of fibrin plays a role in the occurrence of thromboembolic complications of hypertensive patients.

摘要

据报道,不适当的急性血栓形成是高血压(HTN)患者靶器官损伤风险增加和严重程度增加的病理生理基础。然而,HTN 的严重程度与 D-二聚体之间的关系尚未得到很好的描述。本研究旨在评估高血压患者血浆 D-二聚体水平及其与疾病严重程度的相关性。在武汉亚洲心脏病医院对 100 名参与者(60 名高血压患者和 40 名对照者)进行了一项比较性横断面研究。使用相关系数、回归分析以及不同的参数和非参数检验来确定变量之间的相关性。我们观察到高血压患者的 D-二聚体水平明显高于健康对照组(P < 0.001)。随着 HTN 严重程度的增加,D-二聚体水平显著升高(P < 0.001)。在 0.83mg/L 截断值下,D-二聚体在区分复杂和非复杂 HTN 方面具有 86.9%的诊断能力。本研究表明,高血压患者的 D-二聚体水平高于对照组,且随着 HTN 的严重程度而显著升高。这表明纤维蛋白的高凝状态在高血压患者血栓栓塞并发症的发生中起作用。

相似文献

1
Plasma D-dimer levels are correlated with disease severity among hypertensive patients: A comparative cross-sectional study.高血压患者血浆 D-二聚体水平与疾病严重程度相关:一项比较性横断面研究。
Medicine (Baltimore). 2022 Sep 9;101(36):e30281. doi: 10.1097/MD.0000000000030281.
2
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.系统性高血压中内皮、血栓形成和血液流变学与种族及左心室肥厚的关系。
Am J Cardiol. 1997 Dec 15;80(12):1566-71. doi: 10.1016/s0002-9149(97)00749-2.
3
Plasma levels of D-dimer and fibrin degradation products correlate with bullous pemphigoid severity: a cross-sectional study.血浆 D-二聚体和纤维蛋白降解产物水平与大疱性类天疱疮严重程度相关:一项横断面研究。
Sci Rep. 2021 Sep 7;11(1):17746. doi: 10.1038/s41598-021-97202-w.
4
Plasma D-dimer levels are correlated with disease severity among hypertensive patients: A comparative cross-sectional study: Retraction.血浆D-二聚体水平与高血压患者疾病严重程度相关:一项比较性横断面研究:撤稿声明
Medicine (Baltimore). 2022 Oct 28;101(43):e31648. doi: 10.1097/MD.0000000000031648.
5
Correlation analysis between plasma D-dimer levels and orthopedic trauma severity.血浆 D-二聚体水平与骨科创伤严重程度的相关性分析。
Chin Med J (Engl). 2012 Sep;125(17):3133-6.
6
Serum D-dimer Levels Are Proportionally Associated with Left Atrial Enlargement in Patients with an Acute Ischemic Stroke due to Non-valvular Atrial Fibrillation.在非瓣膜性心房颤动所致急性缺血性卒中患者中,血清D-二聚体水平与左心房扩大呈比例相关。
Intern Med. 2016;55(11):1447-52. doi: 10.2169/internalmedicine.55.6087. Epub 2016 Jun 1.
7
Lipoprotein (a), haemostatic variables and cardiovascular damage in hypertensive patients.高血压患者的脂蛋白(a)、止血变量与心血管损伤
J Hypertens. 2000 Jun;18(6):709-16. doi: 10.1097/00004872-200018060-00008.
8
Diagnostic Value of D-Dimer Combined with WBC Count, Neutrophil Percentage and CRP in Differentiating Between Simple and.D-二聚体联合白细胞计数、中性粒细胞百分比及C反应蛋白在鉴别单纯性……中的诊断价值
Clin Lab. 2016 Sep 1;62(9):1675-1681. doi: 10.7754/Clin.Lab.2016.160122.
9
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.慢性心房颤动中血栓形成标志物增加:华法林治疗的影响。
Br Heart J. 1995 Jun;73(6):527-33. doi: 10.1136/hrt.73.6.527.
10
Correlation between Plasma D-Dimer Level and Severity and Prognosis in Patients Admitted at Emergency Department with Trauma.急诊科创伤患者血浆D-二聚体水平与病情严重程度及预后的相关性
Clin Lab. 2020 Jan 1;66(1). doi: 10.7754/Clin.Lab.2019.190520.

引用本文的文献

1
Association between D-Dimer and Long-Term Major Adverse Cardiovascular Outcomes in Patients with Masked Hypertension.隐匿性高血压患者中D-二聚体与长期主要不良心血管事件的关联
Med Princ Pract. 2025 Apr 26:1-9. doi: 10.1159/000546076.
2
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.ADAMTS-13:日本肝硬化患者门静脉血栓形成的预后生物标志物
Int J Mol Sci. 2024 Feb 26;25(5):2678. doi: 10.3390/ijms25052678.
3
Irregularities of Coagulation in Hypertension.高血压患者的凝血异常。
Curr Hypertens Rep. 2023 Oct;25(10):271-286. doi: 10.1007/s11906-023-01258-0. Epub 2023 Aug 10.
4
Association between D-dimer and long-term mortality in patients with acute severe hypertension visiting the emergency department.急诊科急性重症高血压患者D-二聚体与长期死亡率的关联
Clin Hypertens. 2023 Jun 15;29(1):16. doi: 10.1186/s40885-023-00244-7.
5
Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination.接种ChAdOx1 nCoV-19疫苗的泰国人群中抗血小板因子4抗体的纵向研究
Vaccines (Basel). 2023 Mar 17;11(3):692. doi: 10.3390/vaccines11030692.